SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals invests additional Rs 3.82 crore in VKT Pharma

24 May 2017 Evaluate

SMS Pharmaceuticals has further invested an amount of Rs 381.75 lakh in VKT Pharma by subscribing 1,69,665 equity shares, face value of Rs 10 each at a price of Rs 225 per share, including premium of Rs 215 per share, which have been allotted to the company on May 23, 2017. After considering this present acquisition, the total holding of the company is 42.62% in the total paid-up share capital of VKT Pharma.

SMS Pharmaceuticals is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities.



SMS Pharmaceuticals Share Price

427.60 3.45 (0.81%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×